文献速递银屑病与炎症性皮肤病

甲银屑病随机对照试验结局报告的系统综述

Reporting of outcomes in randomized controlled trials on nail psoriasis: a systematic review.
PubMed 文献 · Br J Dermatol · 2018-02-14

该系统综述旨在为甲银屑病核心结局集(COS)开发提供第一步,识别(正在进行的)随机对照试验中使用的结局工具和相应结局域。结果显示结局域包括临床体征、生活质量、症状和护理提供,NAPSI是最常用的临床体征评估工具(74%的研究),但结局工具类型和报告方式异质性高,生活质量评估仅43%的研究涉及,且仅3%使用甲银屑病特异性工具。结论强调需解决异质性并鼓励充分报告工具特征,且需不同研究组合作开发COS。

要点

  • NAPSI是甲银屑病RCT中最常用的临床体征评估工具,占74%的研究。
  • 结局工具类型和报告方式异质性高,工具特征常报告不足。
  • 仅43%的研究评估生活质量,其中仅3%使用甲银屑病特异性工具。

核心结论

  • 甲银屑病结局工具的类型和报告异质性需在COS开发过程中解决。
  • 应鼓励充分报告工具特征,并需不同研究组合作开发COS。

研究设计与样本

  • 系统综述,识别(正在进行的)随机对照试验中使用的结局工具和相应结局域。

主要发现

  • 识别的结局域包括临床体征、生活质量、症状和护理提供。
  • NAPSI是最常用的临床体征评估工具,占74%的研究。
  • 其他工具包括甲面积严重度评分、复合指甲评分、医生整体评估、单个指甲特征或其组合。
  • 结局工具类型和报告(如NAPSI 50、NAPSI 75)异质性高,特征常报告不足。
  • 43%的研究评估生活质量,其中3%使用甲银屑病特异性工具;症状和护理提供评估有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Harmonization of outcome measures is needed to increase the value of clinical trials on nail psoriasis. OBJECTIVES: To provide the first step in core outcome set (COS) development for nail psoriasis. METHODS: A systematic review was performed to identify outcome instruments and corresponding outcome domains used in (ongoing) randomized controlled trials. RESULTS: Identified outcome domains included clinical signs, quality of life, symptoms and delivery of care. The Nail Psoriasis Severity Index (NAPSI) was the most commonly used measure to assess clinical signs (74% of studies). Other outcome instruments used included the Nail Area Severity score, composite fingernail score, a Physician's Global Assessment, individual nail features or a combination of these. Heterogeneity in type and reporting (e.g. NAPSI 50, NAPSI 75) of outcome instruments was high and characteristics were often insufficiently reported. In total 43% of studies assessed quality of life, with 3% of studies using a nail psoriasis-specific tool. Assessment of symptoms and delivery of care was limited. CONCLUSIONS: Heterogeneity in the type and reporting of nail psoriasis outcome instruments needs to be addressed in the process towards COS development. Sufficient reporting of instrument characteristics should be encouraged. As nail psoriasis is generally assessed secondarily to psoriasis of the skin or joints, collaboration between different research groups in COS development is needed.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Busard CI, Nolte JYC, Pasch MC, et al. Reporting of outcomes in randomized controlled trials on nail psoriasis: a systematic review. Br J Dermatol. 2018. PMID: 28722209. doi:10.1111/bjd.15831

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。